Alternative splicing has been recognized as a major mechanism for creating proteomic diversity from a limited number of genes. However, not all determinants regulating this process have been characterized. Using subviral human immunodeficiency virus (HIV) env constructs we observed an enhanced splicing of the RNA when expression was under control of the cytomegalovirus (CMV) promoter instead of the HIV long terminal repeat (LTR). We extended these observations to LTR-or CMV-driven murine leukemia proviruses, suggesting that retroviral LTRs are adapted to inefficient alternative splicing at most sites in order to maintain balanced gene expression.
Alternative splicing has been recognized as a major mechanism for creating proteomic diversity from a limited number of genes. However, not all determinants regulating this process have been characterized. Using subviral human immunodeficiency virus (HIV) env constructs we observed an enhanced splicing of the RNA when expression was under control of the cytomegalovirus (CMV) promoter instead of the HIV long terminal repeat (LTR). We extended these observations to LTR-or CMV-driven murine leukemia proviruses, suggesting that retroviral LTRs are adapted to inefficient alternative splicing at most sites in order to maintain balanced gene expression.
The human proteome exceeds 100,000 isoforms, whereas the number of genes is significantly lower (30,000; reviewed in reference 18). Alternative splicing has been recognized as playing a major role in proteomic diversity related to the ability to generate several different mRNAs from one primary transcript (13) . The same applies to retroviruses. Due to their genomic organization only one polycistronic transcript is made, and this encodes up to nine open reading frames (ORFs) in the case of human immunodeficiency virus (HIV) (6) . Alternative splicing ensures regulated expression of several of these gene products (20) , and mutations that disturb the balance of alternatively spliced transcripts result in severe attenuation (3, 16) . For all retroviruses alternative splicing is regulated via the interplay of cis-acting sequences on the RNA and cellular splicing factors (7, 17, 25) . This regulation involves the presence of both exonic and intronic splicing silencers as well as enhancers. Whereas HIV modulates mostly its 3Ј splice sites (ss) (10), murine leukemia virus (MLV) uses sequences upstream of the 5Ј ss to regulate alternative splicing (14) . Transcription and 3Ј-end processing are closely connected to splicing (12), thus adding one more level to the complex regulation of gene expression. In this report we show that replacing the retroviral long terminal repeat (LTR) with the cytomegalovirus (CMV) promoter shifts the balance of alternatively spliced transcripts, resulting in higher levels of spliced RNA.
In order to study the effects of promoters on alternative splicing in retroviruses we used the previously described NLenv system (Fig. 1A) (2) . This system is based on the HIV-1 proviral clone NL4-3 and generates an mRNA which is identical in sequence to the wild-type env mRNA by removing the sequence between the major 5Ј ss and the env 3Ј ss and restoring the natural exon junction. This RNA can undergo one splicing event, resulting in the nef mRNA (Fig. 1A, left panel) . We exchanged the HIV U3 region with the CMV immediate-early promoter, leaving the transcriptional start site unchanged (Fig.  1A, right panel) . Transfection of these constructs into HelaP4 cells and Western blot analysis showed Rev-dependent Env expression and Rev-independent Nef expression, as expected (Fig. 1B, lanes 1 and 2 and lanes 3 and 4) . Northern blot analysis of total RNA probed with a 3Ј LTR probe detected the unspliced transcript coding for env and the spliced RNA coding for nef (Fig. 1C, lane 3) . The addition of Rev shifted the ratio towards unspliced RNA due to its nuclear export and translation, leading to stabilization of the RNA as an indirect consequence (Fig. 1C, lane 4) (2) . Replacing the U3 region with the CMV promoter led to enhanced splicing of the primary transcript (Fig. 1C, lanes 1 and 3) , although the sequences of the two RNAs are identical and differ only in the nontranscribed promoter region. Interestingly, the CMV promoter seems to function Tat independently in contrast to that of the viral LTR (Fig. 1C , lanes 1 and 2 and lanes 3 and 4), as reported previously (4, 22) .
Since the transactivation by Tat is the major difference between the two promoters we looked at CMV transfections in the presence or absence of Tat. Figure 2A reveals that cotransfection of Tat led to the wild-type splicing pattern (lanes 2 and 4). To obtain transcript levels that were more comparable, the amount of NLCenv plasmid was reduced from 10 to 2 g per 10-cm dish. Still, the CMV promoter was upregulated between two-and fourfold by Tat ( Fig. 2A , lanes 3 and 4, and 2D, lanes 1 and 2) in agreement with previous findings (4, 22) . Since the efficiency of splicing correlates with the amount of nef mRNA and Nef protein, we did Western blot analysis and detected elevated levels of Nef protein in the case of NLCenv compared to that for the wild-type construct and reduced levels upon Tat cotransfection (Fig. 2B) . Quantification of the Northern blot data ( Fig. 2A ) by phosphorimager analysis again illustrated a role for Tat in alternative splicing, namely, that Tat shifts the ratio of spliced versus unspliced RNA back towards wild-type levels (Fig. 2C) .
We extended these observations to a complete proviral HIV clone (NL4-3) driven by the CMV promoter. Here, reduced infectivity (2.4-fold) is measurable (data not shown), but this clone can still produce Tat. Chang and Zhang looked at RNA levels of Tat minus proviral clones driven by hybrid promoters and found only slight difference in RNA levels (5), but the promoter construct differed from the ones reported here. Effects of Tat on alternative splicing were described in a recent report by Berro and colleagues, who established an interaction of acetylated Tat and the splicing inhibitor p32 leading to more unspliced RNA (1). Alternatively, it has also been shown that p32 can bind Rev (15) and that this interaction leads to rescue of excessive splicing in murine cells (26) . We tried to test the Tat hypothesis in our system by using Tat mutants that have little effect on transactivation and should still exert an effect on splicing (1, 19) . The mutants are based on subtype C Tat, whereas we used subtype B Tat (Fig. 2D ). Transfection of NLCenv and different Tat mutants revealed that all of them lead to more unspliced RNA in comparison to the CMV promoter results in the absence of Tat (Fig. 2D and E) . In particular, the K50A mutant showed no defect in transactivation compared to the parental construct (Fig. 2D, lanes 3 and 4) and only a very minor effect on splicing. As a control the K50R mutant behaved exactly like wild-type Tat (Fig. 2D, lanes 3  and 5) .
In order to extend our observations to other retroviruses, we cloned a CMV-driven murine leukemia virus (Fig. 3A) . The construct is based on the MLV clone MOVGFP, which contains eGFP in the proline-rich region of the Env ORF (11) . We exchanged the promoter-leader region to the CMV promoter and sequences from a retroviral vector (SCS11) (24) . As a result both plasmids produced RNAs with identical sequences.
Transfection into 293T cells revealed enhanced splicing when transcription was directed via the CMV (Fig. 3B, lanes 1 and  2) . Whereas the parental MLV clone showed an equal ratio of unspliced and spliced RNAs, the CMV-driven construct showed an almost twofold enhancement of splicing (Fig. 3C) . To evaluate this effect on the protein level, we probed cell lysates with anticapsid or anti-green fluorescent protein (GFP) antibodies (Fig. 2D) , since GFP is encoded within the Env ORF (Fig. 3A) . CMOV11GFP displayed less Gag expression and enhanced Env expression in comparison to the wild-type MLV (Fig. 3D) in agreement with the Northern blot data (Fig.  3B ). This effect can also be measured via flow cytometry detecting the GFP. Here, a fourfold increase in the mean fluorescence intensity in the case of CMOV11GFP also indicates enhanced splicing, leading to more of the GFP Env fusion protein (Fig. 3E) . To determine whether this change in gene expression has any impact on viral titer and therefore more biological relevance, we took supernatants of transient transfections and determined their titers on murine fibroblasts by use of the GFP as a reporter. The enhanced Env expression and reduced Gag expression led to a significant drop in titer, showing that a proper balance of Gag and Env indeed determines infectivity (Fig. 3F ). It will be interesting to look for Effects of the promoter type on alternative splicing events have been reported for the cellular fibronectin gene (8) . Here, the CMV promoter also allowed enhanced inclusion of an alternative exon as found in our NLenv system, where the sequence from the weak nef 3Ј ss to the poly(A) signal can be viewed as the terminal exon (Fig. 1A) . Over the last several years it has become clear that promoters exert their effect on splicing via the processivity or elongation rate of the initiating polymerase (9). It seems that transcription through regulatory elements surrounding alternatively spliced exons and their presentation to the spliceosome determine the outcome of the splicing reaction. These observations have been extended to other genes like alpha tropomyosin (21) and the fibroblast growth factor receptor, where elements that slow down transcription influence splicing ratios (23) . Our findings mark the first report on retroviral promoters and their influence on alternative splicing of the viral transcripts. In both HIV and MLV the CMV promoter leads to excessive splicing, indicating that the viral LTRs are adapted to produce a certain amount of unspliced RNA. For HIV this has been assigned to the Tat 
